catechin has been researched along with Cancer of Esophagus in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 2 (11.11) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Kong, L; Li, X; Meng, X; Wang, Y; Xie, P; Xing, L; Yu, J; Zhang, Y; Zhao, H; Zhu, W | 1 |
Ju, Y; Liu, L; Wang, J; Zhou, R | 1 |
Cai, ZY; Liang, YR; Lu, JL; Shi, YL; Wang, KR; Wang, LX; Xiang, LP; Ye, JH; Zhang, LJ; Zheng, XQ | 1 |
Chen, YC; Gao, Y; Jia, L; Li, B; Li, W; Tu, Y | 1 |
Adriaens, M; Belshaw, NJ; Connor, CA; Johnson, IT; Pierini, R | 1 |
Akanuma, N; Akutsu, Y; Hanari, N; Hoshino, I; Isozaki, Y; Maruyama, T; Matsubara, H; Mori, M; Murakami, K; Nakayama, T; Nishimori, T; Suito, H; Suzuki, A; Takahashi, M; Takeshita, N; Toyozumi, T | 1 |
Gu, S; Hou, L; Huang, S; Liu, L; Luo, M; Meng, D; Zhang, X; Zhao, X; Zuo, X | 1 |
Belshaw, NJ; Guyot, S; Johnson, IT; Kroon, PA; Pierini, R | 1 |
Belshaw, NJ; Guyot, S; Ivory, K; Johnson, IT; Kroon, PA; Pierini, R | 1 |
Guan, BX; Xu, XC; Ye, F; Zhang, GH | 1 |
Imamura, M; Itami, A; Kaganoi, J; Kawabe, A; Komoto, I; Li, ZG; Maeda, M; Sato, F; Shimada, Y | 1 |
Ai, N; Fang, MZ; Hou, Z; Lu, H; Sun, Y; Wang, Y; Welsh, W; Yang, CS | 1 |
Ho, CT; Hong, J; Hou, Z; Huang, MT; Lambert, JD; Rosen, RT; Ryu, JH; Sang, S; Stark, RE; Tian, S; Yang, CS | 1 |
Chin, KV; Hong, J; Hou, Z; Lee, MJ; Sang, S; Yang, CS; You, H | 1 |
Balentine, DA; Boone, CW; Harbowy, ME; Kelloff, GJ; Kresty, LA; Morse, MA; Steele, VE; Stoner, GD | 1 |
Chen, L; Lee, MJ; Yang, CS | 1 |
Morris, K | 1 |
Gothoskar, SV; Ranadive, KJ; Ranadive, SN; Shivapurkar, NM | 1 |
1 review(s) available for catechin and Cancer of Esophagus
Article | Year |
---|---|
Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer.
Topics: Antineoplastic Agents; Catechin; Cell Proliferation; DNA Methylation; Esophageal Neoplasms; Humans; Polyphenols; Signal Transduction; Tea | 2019 |
1 trial(s) available for catechin and Cancer of Esophagus
Article | Year |
---|---|
Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer.
Topics: Adult; Aged; Catechin; Chemoradiotherapy; China; Esophageal Neoplasms; Esophagitis; Female; Humans; Male; Middle Aged; Prospective Studies; Radiation Injuries | 2020 |
16 other study(ies) available for catechin and Cancer of Esophagus
Article | Year |
---|---|
Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Membrane Potential, Mitochondrial; Neoplasm Proteins; Signal Transduction; Time Factors | 2017 |
Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Biflavonoids; Caspase 3; Caspase 9; Catechin; Cell Line, Tumor; Enzyme Inhibitors; Esophageal Neoplasms; Gallic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Signaling System | 2013 |
Procyanidin induces apoptosis of esophageal adenocarcinoma cells via JNK activation of c-Jun.
Topics: Adenocarcinoma; Apoptosis; Biflavonoids; Caspase 3; Caspase 7; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Proanthocyanidins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-jun; Signal Transduction; Transcription Factor AP-1; Up-Regulation | 2014 |
Screening of alternative drugs to the tumor suppressor miR-375 in esophageal squamous cell carcinoma using the connectivity map.
Topics: Antineoplastic Agents; Apoptosis; Benzocaine; Betazole; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Chenodeoxycholic Acid; Cytotoxins; DNA Primers; Esophageal Neoplasms; Humans; In Situ Nick-End Labeling; Metformin; MicroRNAs; Nizatidine; Organophosphates; Proline; Protein Array Analysis; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Transcriptome; Transfection; Tumor Suppressor Proteins | 2014 |
Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G1 Phase Cell Cycle Checkpoints; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Reactive Oxygen Species; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |
The procyanidin-mediated induction of apoptosis and cell-cycle arrest in esophageal adenocarcinoma cells is not dependent on p21(Cip1/WAF1).
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Biflavonoids; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Proanthocyanidins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Up-Regulation | 2008 |
Procyanidin effects on oesophageal adenocarcinoma cells strongly depend on flavan-3-ol degree of polymerization.
Topics: Adenocarcinoma; Apoptosis; Biflavonoids; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Dimerization; Esophageal Neoplasms; Flavonoids; Humans; Malus; MAP Kinase Signaling System; Polymers; Proanthocyanidins | 2008 |
Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.
Topics: Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Catechin; Cell Line, Tumor; Curcumin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Lovastatin; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 2012 |
Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Dimethylnitrosamine; Dinoprostone; Disease Models, Animal; DNA Primers; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophagus; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator | 2002 |
Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
Topics: Adaptor Proteins, Signal Transducing; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Carrier Proteins; Catechin; Cell Division; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Humans; Models, Molecular; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; Receptors, Retinoic Acid | 2003 |
Enzymatic synthesis of tea theaflavin derivatives and their anti-inflammatory and cytotoxic activities.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Biflavonoids; Biochemistry; Carcinoma, Squamous Cell; Catechin; Cell Division; Cells, Cultured; Colonic Neoplasms; Drug Evaluation, Preclinical; Ear Diseases; Edema; Esophageal Neoplasms; Female; Horseradish Peroxidase; Humans; Macrophages; Mice; Mice, Inbred Strains; Structure-Activity Relationship; Tea; Tetradecanoylphorbol Acetate; Toxicity Tests; Tumor Cells, Cultured | 2004 |
Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Topics: Benzopyrans; Biflavonoids; Carcinoma, Squamous Cell; Catechin; Cell Growth Processes; Cell Line, Tumor; Drug Stability; ErbB Receptors; Esophageal Neoplasms; Gallic Acid; Humans; Oxidation-Reduction; Phenols; Phosphorylation; Receptor, ErbB-2; Superoxide Dismutase | 2005 |
Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis.
Topics: Animals; Benzocycloheptenes; Biological Assay; Catechin; Dimethylnitrosamine; Esophageal Neoplasms; Gallic Acid; Male; Molecular Structure; Phenols; Rats; Rats, Inbred F344; Tea | 1997 |
Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies.
Topics: Absorption; Adult; Anticarcinogenic Agents; Beverages; Capsules; Catechin; Drinking; Esophageal Neoplasms; Esterases; Female; Flavonoids; Free Radical Scavengers; Half-Life; Humans; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Saliva; Tea | 1999 |
Tea chemicals confirmed as cancer-busting compounds.
Topics: Case-Control Studies; Catechin; Cohort Studies; Esophageal Neoplasms; Flavonoids; Humans; Male; Middle Aged; Phenols; Polymers; Prospective Studies; Stomach Neoplasms; Tea | 2002 |
Betel quid chewing and oral cancer: experimental studies on hamsters.
Topics: Animals; Areca; Carcinoma, Squamous Cell; Catechin; Cheek; Cricetinae; Esophageal Neoplasms; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental; Nicotiana; Plants, Medicinal; Plants, Toxic | 1979 |